Mumbai: Eli Lilly‘s breakthrough weight-loss and diabetes drug Mounjaro has stunned the Indian pharmaceutical market, rising to the no. 2 position in sales within six months of its launch – a feat rarely seen in recent pharma history. Mounjaro posted sales of ₹80 crore in September, closely trailing the legacy antibiotic brand Augmentin (₹85 crore)…
Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly’s key drugs, including those for…
Novo Nordisk‘s and Eli Lilly‘s blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity and its complications, a major European medical association advised on Thursday. Semaglutide, the active ingredient in Novo’s Wegovy and Ozempic, and tirzepatide, sold as Zepbound and Mounjaro by Lilly, are so effective that they should be…
Eli Lilly has paused shipments of its type 2 diabetes and weight loss therapy Mounjaro to the UK, ahead of a price increase next month that has reportedly led patients to start stockpiling the drug. The company said in mid-August that it would raise the list price of dual GLP-1/GIP agonist Mounjaro (tirzepatide) in the…
The Indian Medical Association (IMA) has sounded a warning bell on the potential misuse and mis-prescription of weight-loss drugs, such as Wegovy and Mounjaro. These GLP-1 medications, IMA national president Dilip Bhanushali told ET should only be prescribed by certified endocrinologists or diabetologists. IMA, the country’s largest organisation of modern medicine practitioners, will formally write…
MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk, maker of blockbuster weight-loss drug Wegovy (semaglutide), claiming its version of the drug does not infringe upon the device or process patent technology owned by the multinational company. The case came up for hearing in Delhi High Court on Wednesday. “The court has directed the…
Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli Lilly We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Mounjaro, Wegovy sales in India double on month in July We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
US drugmaker Eli Lilly‘s weight-loss drug Mounjaro (tirzepatide) has crossed Rs 100 crore in sales in India in just four months of launch, making it one of the country’s fastest-growing prescription brands ever by value. The drug clocked Rs 47-crore sales in July, double its June figure, according to data from prescriptions tracker PharmaTrac. If…
Sales of Danish drugmaker Novo Nordisk‘s Wegovy and U.S. rival Eli Lilly’s Mounjaro in India doubled in July from a month earlier, data from research firm Pharmarack showed on Thursday. Demand for the blockbuster anti-obesity drugs, which help control blood sugar and slow digestion, has been on an upswing in the world’s most populous nation….